Sun BioPharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sun BioPharma and buy or sell other stocks, ETFs, and their options commission-free!

About SNBP

Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. 

CEO
Jennifer K. Simpson, PhD
CEOJennifer K. Simpson, PhD
Employees
Employees
Headquarters
Waconia, Minnesota
HeadquartersWaconia, Minnesota
Founded
2011
Founded2011
Employees
Employees

SNBP Key Statistics

Market cap
19.42M
Market cap19.42M
Price-Earnings ratio
-0.03
Price-Earnings ratio-0.03
Dividend yield
Dividend yield
Average volume
Average volume
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$1.11
52 Week high$1.11
52 Week low
$1.11
52 Week low$1.11

Stock Snapshot

With a market cap of 19.42M, Sun BioPharma(SNBP) trades at $4.00. The stock has a price-to-earnings ratio of -0.03.

During the trading day, Sun BioPharma(SNBP) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Sun BioPharma(SNBP) stock has reached 0.

Over the past 52 weeks, Sun BioPharma(SNBP) stock has traded between a high of $1.11 and a low of $1.11.

Over the past 52 weeks, Sun BioPharma(SNBP) stock has traded between a high of $1.11 and a low of $1.11.

People also own

Based on the portfolios of people who own SNBP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.